Methods of use of histamine H2 agonists in treating dry eye
作者： John M. Yanni , Daniel A. Gamache , Steven T. Miller
DOI:
关键词:
摘要: A topical ophthalmic composition for the treatment of dry eye in humans, comprising one or more histamine H 2 agonists, is disclosed.
lens.org 参考文章(26)
Mark B. Abelson, Compositions and method for treating red eye ,(1980)
I K Gipson, S J Spurr-Michaud, H Watanabe, K Lindberg, A S Tisdale, M Fabricant, Human corneal and conjunctival epithelia produce a mucin-like glycoprotein for the apical surface. Investigative Ophthalmology & Visual Science. ,vol. 36, pp. 337- 344 ,(1995)
Lemp Ma, Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc. ,vol. 21, pp. 221- 232 ,(1995)
Albert M. Packman, Pharmaceutical compositions and method of treatment ,(1979)
Frank J. Holly, Ophthalmic solution for treatment of dry-eye syndrome ,(1986)
William Kreutner, John A. Hey, Treatment of upper airway allergic responses ,(1997)
John Urquhart, Method and therapeutic system for treating aqueous deficient dry eye ,(1975)
Philip D. Gressel, Robert E. Roehrs, Henry F. Edelhauser, John L. Ubels, Topical ophthalmic compositions containing microfine retinoid particles ,(1989)
Philip D. Gressel, Robert E. Roehrs, Ophthalmic carboxy vinyl polymer gel for dry eye syndrome ,(1990)